DANIEL CALLAHAN: Open Payments
NPI 1265998439 · PEACHTREE CITY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,736 in 95 payments from 21 companies in 2025. Trend: 2023 $1,172 · 2024 $1,532 · 2025 $1,736
Food & beverage: $1,736
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $277 |
| Axsome Therapeutics, Inc. | 9 | $220 |
| ABBVIE INC. | 17 | $195 |
| PFIZER INC. | 11 | $168 |
| Lilly USA, LLC | 9 | $150 |
| Novo Nordisk Inc | 6 | $125 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $82 |
| Corcept Therapeutics | 3 | $81 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Amgen Inc. | 4 | $64 |
Products named: AIRSUPRA, NURTEC ODT, REXULTI, Symbravo, Auvelity, VRAYLAR, FARXIGA, MOUNJARO.
Industry payments across GA — which companies pay providers there.
